Stay updated on AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly
Sign up to get notified when there's something new on the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page.

Latest updates to the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe NIH transition announcement about site updates and changing terminology from “Artificial Intelligence” to “Super Intelligence” is no longer displayed. The page still shows a 403 error rather than the study record.SummaryDifference1%

- Check17 days agoChange DetectedThe footer’s site revision label changes from v3.7.2 to v3.8.0, while the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces an NIH-wide transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study page’s main content has been replaced by a 403 Forbidden message and a Home link.SummaryDifference0.5%

Stay in the know with updates to AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly
Enter your email address, and we'll notify you when there's something new on the AVOID Trial: Lipegfilgrastim vs Pegfilgrastim in Elderly page.